These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16814011)
41. Gender differences in the impact of comprehensive services in substance abuse treatment. Marsh JC; Cao D; D'Aunno T J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830 [TBL] [Abstract][Full Text] [Related]
42. Family-centered interventions for substance abuse in Hispanic communities. Sparks SN; Tisch R; Gardner M J Ethn Subst Abuse; 2013; 12(1):68-81. PubMed ID: 23480212 [TBL] [Abstract][Full Text] [Related]
43. Counting apples as oranges: epidemiology and ethnography in adolescent substance abuse treatment. Reisinger HS Qual Health Res; 2004 Feb; 14(2):241-58. PubMed ID: 14768460 [TBL] [Abstract][Full Text] [Related]
44. Examining the effects of sex and ethnicity on substance abuse treatment and mediational pathways. Morgenstern J; Bux DA Alcohol Clin Exp Res; 2003 Aug; 27(8):1330-2. PubMed ID: 12966332 [No Abstract] [Full Text] [Related]
47. [Drug abuse in Mexico. IV. Therapeutic programs]. RamÃrez-Moreno A Gac Med Mex; 1979 Nov; 115(11):491-4. PubMed ID: 540719 [No Abstract] [Full Text] [Related]
48. Identifying United States substance abuse treatment programs: a test in one mid-sized city. Carise D; McLellan AT; Festinger DS; Kleber HD Subst Abus; 2004 Jun; 25(2):21-8. PubMed ID: 15982964 [TBL] [Abstract][Full Text] [Related]
49. Program characteristics and readmission among older substance abuse patients: comparisons with middle-aged and younger patients. Moos RH; Mertens JR; Brennan PL J Ment Health Adm; 1995; 22(4):332-45. PubMed ID: 10172450 [TBL] [Abstract][Full Text] [Related]
50. Program characteristics for successful treatment of adolescent drug abuse. Friedman AS; Glickman NW J Nerv Ment Dis; 1986 Nov; 174(11):669-79. PubMed ID: 3772356 [TBL] [Abstract][Full Text] [Related]
51. [Treatment programs for patients with substance-induced mental disorders]. Murakami Y; Hiejima M; Yuzauri T; Endo K Seishin Shinkeigaku Zasshi; 2001; 103(3):274-80. PubMed ID: 11383144 [No Abstract] [Full Text] [Related]
52. Using recidivism rates as a quality indicator for substance abuse treatment programs. Thakur NM; Hoff RA; Druss B; Catalanotto J Psychiatr Serv; 1998 Oct; 49(10):1347-50. PubMed ID: 9779909 [TBL] [Abstract][Full Text] [Related]
53. A national survey of primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005 to 2006. Callaghan RC; Tavares J; Taylor L; Veldhuizen S Can J Psychiatry; 2007 Oct; 52(10):684-8. PubMed ID: 18020116 [TBL] [Abstract][Full Text] [Related]
54. Goodbye to the binge: the recovery house. Cole W Time; 2004 Sep; 164(12):67. PubMed ID: 15485200 [No Abstract] [Full Text] [Related]
55. Adolescent chemical dependency treatment in an HMO. Freeborn DK; Beaudet MP; Mullooly JP; Boehm RD; Brenes J HMO Pract; 1991; 5(2):44-50. PubMed ID: 10170804 [TBL] [Abstract][Full Text] [Related]
56. Minimizing substance misuse by strategies to strengthen families. Vimpani G; Spooner C Drug Alcohol Rev; 2003 Sep; 22(3):251-4. PubMed ID: 15385218 [No Abstract] [Full Text] [Related]
57. Predictors of substance abuse treatment outcomes in Tennessee. Kedia S; Williams C J Drug Educ; 2003; 33(1):25-47. PubMed ID: 12773023 [TBL] [Abstract][Full Text] [Related]